Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.
NCT07583147
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
117
Enrollment
OTHER
Sponsor class
Conditions
Intracerebral Hemorrhage
Interventions
DRUG:
TEP with 18F-DPA-714 injection
Sponsor
University Hospital, Toulouse